Respiratory sleep disturbance in children and adolescents with cystic fibrosis

Sleep disturbance has been described in cystic fibrosis (CF) patients as relevant to clinical and lung function predictive factors helping to improve the diagnosis and early intervention. Related paediatric studies are scarce. Objective: To describe respiratory sleep disturbance (RSD) and its associ...

Full description

Bibliographic Details
Main Authors: A.M. Silva, A. Descalço, M. Salgueiro, L. Pereira, C. Barreto, T. Bandeira, R. Ferreira
Format: Article
Language:English
Published: Elsevier 2016-07-01
Series:Revista Portuguesa de Pneumologia (English Edition)
Online Access:http://www.sciencedirect.com/science/article/pii/S2173511516000439
id doaj-bd5133620aea4ae0913b749b7f2d38f2
record_format Article
spelling doaj-bd5133620aea4ae0913b749b7f2d38f22020-11-25T01:05:13ZengElsevierRevista Portuguesa de Pneumologia (English Edition)2173-51152016-07-01224202208Respiratory sleep disturbance in children and adolescents with cystic fibrosisA.M. Silva0A. Descalço1M. Salgueiro2L. Pereira3C. Barreto4T. Bandeira5R. Ferreira6Pediatric Lung Function and Sleep Laboratory, Hospital de Santa Maria, CHLN, Lisbon Academic Medical Center, Portugal; Corresponding author.Pediatric Lung Function and Sleep Laboratory, Hospital de Santa Maria, CHLN, Lisbon Academic Medical Center, PortugalPediatric Lung Function and Sleep Laboratory, Hospital de Santa Maria, CHLN, Lisbon Academic Medical Center, PortugalRespiratory Unit, Department of Pediatrics, Hospital de Santa Maria, CHLN, Lisbon Academic Medical Center, PortugalDepartment of Pediatrics, Hospital de Santa Maria, CHLN, Lisbon Academic Medical Center, PortugalPediatric Lung Function and Sleep Laboratory, Hospital de Santa Maria, CHLN, Lisbon Academic Medical Center, Portugal; Respiratory Unit, Department of Pediatrics, Hospital de Santa Maria, CHLN, Lisbon Academic Medical Center, PortugalPediatric Lung Function and Sleep Laboratory, Hospital de Santa Maria, CHLN, Lisbon Academic Medical Center, Portugal; Respiratory Unit, Department of Pediatrics, Hospital de Santa Maria, CHLN, Lisbon Academic Medical Center, PortugalSleep disturbance has been described in cystic fibrosis (CF) patients as relevant to clinical and lung function predictive factors helping to improve the diagnosis and early intervention. Related paediatric studies are scarce. Objective: To describe respiratory sleep disturbance (RSD) and its association with spirometric indices in a population of CF children. A second aim was to determine if spirometric indices and wake-time SpO2 are predictors of sleep disturbance. Methods: A cross-sectional study involving 33CF paediatric patients. All participants underwent in-lab polysomnography (PSG), pulse oximetry and spirometry. A standardized sleep questionnaire was completed for each patient. Two subgroups were considered: I â Normal (FEV1 > â1.64 z-score); II â Obstructed (FEV1 â¤Â â1.64 z-score). Results: Participant's median age was 12 (6â18) years, 16 (48.5%) were male. Twenty-nine patients (87.9%) presented sleep complaints. Sleep efficiency was reduced; sleep latency and waking after sleep onset (WASO) increased. N1 increased, N2, N3, REM and awakenings were normal. The apnoeaâhypopnoea index was 0.6/h (sd 0.9); respiratory disturbance index (RDI) was 6.6/h (sd 5.2). Mean awaking (97% (sd 1.1)) and sleep SpO2 (95% (sd 2.7)) were normal; mean nocturnal oximetry desaturation index was 2.36/h; minimal nocturnal SpO2 was 89% (sd 4.1).We found associations between mean nocturnal SPO2 and mean values of FEV1 (r = 0.528; p = 0.002) and FEF25â75 (r = 0.426; p = 0.013). There were significant differences in nocturnal SpO2 between normal and obstructed patients (p < 0.000). PSG data correlated with the questionnaire answers for night awakenings and WASO (p = 0.985) and difficult breathing during sleep and RDI (p = 0.722).This study points to most CF children having sleep complaints, and highlights the correlation between subjective assessment of sleep and PSG and spirometric results. Awake-time SpO2 and spirometric values are possible risk predictors for nocturnal desaturation. Keywords: Sleep disturbance, Polysomnography, Spirometry, Cystic fibrosis, Childrenhttp://www.sciencedirect.com/science/article/pii/S2173511516000439
collection DOAJ
language English
format Article
sources DOAJ
author A.M. Silva
A. Descalço
M. Salgueiro
L. Pereira
C. Barreto
T. Bandeira
R. Ferreira
spellingShingle A.M. Silva
A. Descalço
M. Salgueiro
L. Pereira
C. Barreto
T. Bandeira
R. Ferreira
Respiratory sleep disturbance in children and adolescents with cystic fibrosis
Revista Portuguesa de Pneumologia (English Edition)
author_facet A.M. Silva
A. Descalço
M. Salgueiro
L. Pereira
C. Barreto
T. Bandeira
R. Ferreira
author_sort A.M. Silva
title Respiratory sleep disturbance in children and adolescents with cystic fibrosis
title_short Respiratory sleep disturbance in children and adolescents with cystic fibrosis
title_full Respiratory sleep disturbance in children and adolescents with cystic fibrosis
title_fullStr Respiratory sleep disturbance in children and adolescents with cystic fibrosis
title_full_unstemmed Respiratory sleep disturbance in children and adolescents with cystic fibrosis
title_sort respiratory sleep disturbance in children and adolescents with cystic fibrosis
publisher Elsevier
series Revista Portuguesa de Pneumologia (English Edition)
issn 2173-5115
publishDate 2016-07-01
description Sleep disturbance has been described in cystic fibrosis (CF) patients as relevant to clinical and lung function predictive factors helping to improve the diagnosis and early intervention. Related paediatric studies are scarce. Objective: To describe respiratory sleep disturbance (RSD) and its association with spirometric indices in a population of CF children. A second aim was to determine if spirometric indices and wake-time SpO2 are predictors of sleep disturbance. Methods: A cross-sectional study involving 33CF paediatric patients. All participants underwent in-lab polysomnography (PSG), pulse oximetry and spirometry. A standardized sleep questionnaire was completed for each patient. Two subgroups were considered: I â Normal (FEV1 > â1.64 z-score); II â Obstructed (FEV1 â¤Â â1.64 z-score). Results: Participant's median age was 12 (6â18) years, 16 (48.5%) were male. Twenty-nine patients (87.9%) presented sleep complaints. Sleep efficiency was reduced; sleep latency and waking after sleep onset (WASO) increased. N1 increased, N2, N3, REM and awakenings were normal. The apnoeaâhypopnoea index was 0.6/h (sd 0.9); respiratory disturbance index (RDI) was 6.6/h (sd 5.2). Mean awaking (97% (sd 1.1)) and sleep SpO2 (95% (sd 2.7)) were normal; mean nocturnal oximetry desaturation index was 2.36/h; minimal nocturnal SpO2 was 89% (sd 4.1).We found associations between mean nocturnal SPO2 and mean values of FEV1 (r = 0.528; p = 0.002) and FEF25â75 (r = 0.426; p = 0.013). There were significant differences in nocturnal SpO2 between normal and obstructed patients (p < 0.000). PSG data correlated with the questionnaire answers for night awakenings and WASO (p = 0.985) and difficult breathing during sleep and RDI (p = 0.722).This study points to most CF children having sleep complaints, and highlights the correlation between subjective assessment of sleep and PSG and spirometric results. Awake-time SpO2 and spirometric values are possible risk predictors for nocturnal desaturation. Keywords: Sleep disturbance, Polysomnography, Spirometry, Cystic fibrosis, Children
url http://www.sciencedirect.com/science/article/pii/S2173511516000439
work_keys_str_mv AT amsilva respiratorysleepdisturbanceinchildrenandadolescentswithcysticfibrosis
AT adescalao respiratorysleepdisturbanceinchildrenandadolescentswithcysticfibrosis
AT msalgueiro respiratorysleepdisturbanceinchildrenandadolescentswithcysticfibrosis
AT lpereira respiratorysleepdisturbanceinchildrenandadolescentswithcysticfibrosis
AT cbarreto respiratorysleepdisturbanceinchildrenandadolescentswithcysticfibrosis
AT tbandeira respiratorysleepdisturbanceinchildrenandadolescentswithcysticfibrosis
AT rferreira respiratorysleepdisturbanceinchildrenandadolescentswithcysticfibrosis
_version_ 1725195610796064768